Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)

Completed · Not applicable

Conditions studied: Children at Risk for ASD

In brief

The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.

Key facts

Study ID

NCT01874327

Run by

University of California, Los Angeles

People needed

110

Starts

2013-01-01

Expected to finish

2018-09-01

Last updated by the study team

2018-10-10

Who can join

Age: 1 and older, up to 2. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have elevated scores on the ADOS-Toddler version and clinical concern from professional (Pediatrician, Psychologist, etc). Because of the young age of children, we expect to intervene with children who do not yet have a diagnosis of ASD but may only show some risk by virtue of elevated scores on the ADOS-T.
• Have a parent available for parent-mediated sessions 2 times per week in the classroom
• Do not have seizures
• Do not have associated sensory or physical disorders
• Are not co-morbid with other syndromes or diseases

You may not qualify if…

• Other co-morbid syndromes or diseases
• Seizure activity
• Other sensory or physical disorders

Where it is running

• UCLA Semel Institue — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.